StockDriftsCYBIN INC. · CYBN · 6-K · Filed
CEO to participate in Morgan Stanley Healthcare Conference fireside chat
CYBN
6-K
Other filings
Source: SEC EDGAR, accession 0001833141-26-000074
What did CYBIN INC. announce?
Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference.
Key details
- CEO Michael Halstead will speak on September 16, 2026, at 8:30 a.m. EDT.
- The fireside chat will be webcast live.
Why it matters
This 6-K reports a corporate disclosure at CYBIN INC.. The likely share-price reaction reads as neutral.
Neutral